Phase I study of DQ-2556, a new parenteral 3-quaternary ammonium cephalosporin antibiotic.

Nakashima, M; Uematsu, T; Kanamaru, M; Mizuno, A; Matsubayashi, K; Okazaki, O; Hashimoto, S; Hakusui, H; Osada, Y

Nakashima, M; Uematsu, T; Kanamaru, M; Mizuno, A; Matsubayashi, K; Okazaki, O; Hashimoto, S; Hakusui, H; Osada, Y.

Affiliation

Nakashima M; Department of Pharmacology, Hamamatsu University School of Medicine, Japan.

J Clin Pharmacol ; 33(1): 57-62, 1993 Jan.

Article in En | MEDLINE | ID: mdl-8429115

Subject(s)

Cephalosporins; Adult; Cephalosporins/administration & dosage; Cephalosporins/adverse effects; Cephalosporins/pharmacokinetics; Drug Administration Schedule; Drug Tolerance; Humans; Infusions, Intravenous; Injections, Intramuscular; Male; Middle Aged

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Cephalosporins Type of study: Prognostic_studies Limits: Adult / Humans / Male / Middle aged Language: En Year: 1993 Type: Article

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Cephalosporins Type of study: Prognostic_studies Limits: Adult / Humans / Male / Middle aged Language: En Year: 1993 Type: Article